Skip to content

The effect of licorice syrup on dysmenorrhea

The effect of licorice syrup on primary dysmenorrhea compared with Ibuprofen

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015081323610N1
Enrollment
60
Registered
2016-02-17
Start date
2015-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea. Primary dysmenorrhea

Interventions

Intervention 1: Intervention Group: licorice syrup at a dose of 5 mL twice daily and placebo every 8 hours during the first five days of each cycle and for two consecutive cycles. Intervention 2: Cont
Treatment - Drugs
Intervention Group: licorice syrup at a dose of 5 mL twice daily and placebo every 8 hours during the first five days of each cycle and for two consecutive cycles
Control Group: Ibuprofen 400 mg every 8 hours and 5 ml of placebo syrup twice a day, during the first five days of each cycle and for two consecutive cycles

Sponsors

Vice Chancellor for research, Shahid Sadoughei University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 25 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Aged between 18-25 years; Moderate and severe dysmenorrhea (grade 2, 3) based on Verbal Multidimensional Scoring System; Regular menstrual cycles (every 21-35 days and bleeding 3 to 10 days for at least three recent cycles). Exclusion criteria: Pelvic pathology (including Endometriosis, Adenomyosis, Fibroids, Ovarian Cysts, Pelvic Inflammatory Disease, etc); Known diseases (including Chronic Hepatitis, Cholestatic Liver Disease, Cirrhosis, Severe Renal Insufficiency, Diabetes Mellitus, Arrhythmias, Hypertension, Hypertonia and Hypokalemia); Existence of stressors (such as loss of a close relative and Intense familial debate) during recent 6 months; History of allergy to licorice; Concurrent use of other products containing licorice; Taking another painkiller that is not defined in the study; Concomitant use of OCP; Drug intolerance; Lack of desire to continue the treatment for any reason; Another disease that will have required medical treatment during the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: Before intervention- Every day during intervention. Method of measurement: Visual Analogue Scale(VAS).;Pain duration. Timepoint: Before intervention- Every day during intervention. Method of measurement: hour.

Secondary

MeasureTime frame
Adverse effect of licorice syrup. Timepoint: At the end of each cycle of intervention. Method of measurement: Questionnaire.;Adverse effect of Ibuprofen such as Nausea, dyspepsia, vomiting, ulcers and gastrointestinal bleeding. Timepoint: At the end of each cycle of intervention. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactzahra jafari

Faculty of Traditional Medicine, Shahid Sadoughei University of Medical Sciences, Ardakan, Yazd

z-jafari@razi.tums.ac.ir+98 35 2723 8917

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026